590281

AstraZeneca Pharmaceuticals LP — FEI 3002617771

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 18, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Frederick, MD (United States)